A study finds that a majority of medicinal cannabidiol (CBD) products in the online market are actually mislabeled. This could cause potential harm to the growing number of CBD users.
A team of researchers tested the labeling accuracy of medicinal CBD products online and found that nearly 70 percent of them are mislabeled. For a month, the researchers identified and purchased CBD products that had CBD labeled as a product content on the packaging. They then analyzed the 84 products from 31 different companies using high-performance liquid chromatography and found that 42 percent of the products were under-labeled, or had higher concentrations of CBD than is stated in the packaging, while 26 percent were over-labeled, or had lower concentrations of CBD than claimed.
Among the tested products, only 30 percent were found to be within the acceptable range, or 10 percent within the concentration indicated on the label.
Researchers note that it has yet to be proven that CBD is dangerous in high concentrations. Still, the potential clinical benefits to the patients may be compromised by the over- or under-dosed CBD products.
“The biggest implication is that many of these patients may not be getting the proper dosage; they’re either not getting enough for it to be effective or they’re getting too much,” said Marcel Bonn-Miller, PhD, professor of Psychology in Psychiatry and lead author of the study.
What’s more, some of the tested products were found to contain significant amounts of tetrahydrocannabinol (THC), which is the chemical compound in cannabis that makes people feel “high.” This is a significant finding as many people, even children, are beginning to use CBD to treat their conditions. As such, parents could have been unknowingly giving their children THC.
In recent years, more and more people have been